Literature DB >> 34816056

Comparing COVID-19 mortality across selected states in India: The role of age structure.

Mohamed Jainul Azarudeen1, Khyati Aroskar1, Karishma Krishna Kurup2, Tanzin Dikid1, Himanshu Chauhan1, S K Jain1, S K Singh1.   

Abstract

BACKGROUND: Mortality rates provide an opportunity to identify and act on the health system intervention for preventing deaths. Hence, it is essential to appreciate the influence of age structure while reporting mortality for a better summary of the magnitude of the epidemic.
OBJECTIVES: We described and compared the pattern of COVID-19 mortality standardized by age between selected states and India from January to November 2020.
METHODS: We initially estimated the Indian population for 2020 using the decadal growth rate from the previous census (2011). This was followed by estimations of crude and age-adjusted mortality rate per million for India and the selected states. We used this information to perform indirect-standardization and derive the age-standardized mortality rates for the states for comparison. In addition, we derived a ratio for age-standardized mortality to compare across age groups within the state. We extracted information regarding COVID-19 deaths from the Integrated Disease Surveillance Programme special surveillance portal up to November 16, 2020.
RESULTS: The crude mortality rate of India stands at 88.9 per million population (118,883/1,337,328,910). Age-adjusted mortality rate (per-million) was highest for Delhi (300.5) and lowest for Kerala (35.9). The age-standardized mortality rate (per million) for India is (<15 years = 1.6, 15-29 years = 6.3, 30-44 years = 35.9, 45-59 years = 198.8, 60-74 years = 571.2, ≥75 years = 931.6). The ratios for age-standardized mortality increase proportionately from 45 to 59 years age group across all the states.
CONCLUSION: There is high COVID-19 mortality not only among the elderly ages, but we also identified heavy impact of COVID-19 on the working population. Therefore, we recommend further evaluation of age-adjusted mortality for all States and inclusion of variables like gender, socio-economic status for standardization while identifying at-risk populations and implementing priority public health actions.
© 2021 The Authors.

Entities:  

Keywords:  Age standardized mortality rate; COVID-19; Indirect standardization; Mortality

Year:  2021        PMID: 34816056      PMCID: PMC8602842          DOI: 10.1016/j.cegh.2021.100877

Source DB:  PubMed          Journal:  Clin Epidemiol Glob Health        ISSN: 2213-3984


Introduction

World Health Organization declared COVID-19 a pandemic on March 11, 2020. In India, the first case was reported on January 27, 2020, in a 20-year-old female at Thrissur city, Kerala. As of early November 2020, India recorded the second-highest number of COVID-19 cases (8 million), next only to the US (9.2 million). India is third in the number of deaths (121,144), behind Brazil (159,033) and the US (234,222). Given the population of India, these numbers may seem comparable, but most numbers are concentrated in specific states of India. Mortality rates provide an opportunity to identify and act on the health system intervention for preventing deaths. The Sustainable Development Goal-3 uses mortality as a marker to gauge and recognize preventable deaths to fortify early recognition and hazard reduction interventions. COVID-19 mortality is an important estimate to know the disease burden in the community. Case fatality rate (CFR), the ratio of COVID-19 deaths to diagnosed cases, is the commonly reported measure to quantify mortality due to a disease. This measure is dependent on reported case numbers which can vary due to the fluctuations in testing protocols, changing case definitions, and surveillance capacity. This poses a dilemma in a populous country like India, which houses different age structures in its states and has reported a significant difference in adult mortality within districts. The cases may be missed, but deaths are tangible. Thus, the regional disparity needs to be studied to assess the COVID-19 pandemic situation in India better. Hence, it is necessary to appreciate the influence of age structure while reporting mortality to summarise the magnitude of the epidemic better. With this objective in mind, we examined the pattern of COVID-19 mortality of India and selected states, taking into account the respective age structure and presenting the crude, age-adjusted mortality rate and age-standardized mortality rates from January to November 2020.

Methodology

We reviewed the available reports of all the states for the absolute number of COVID-19 deaths reported to the Integrated Disease Surveillance Programme (IDSP) on November 16, 2020, and compared them with the State-wise bulletins. We then identified seven states (Maharashtra, Karnataka, Tamil Nadu, Haryana, West Bengal and Kerala), including one union territory (Delhi) based on the completeness and validity of reported COVID-19 deaths. We extracted COVID-19 deaths for the age groups from the IDSP COVID-19 special surveillance portal until November 16, 2020, and the daily COVID-19 bulletin of the respective states. The state-based COVID-19 mortality figures for the specific age groups were extracted from the data portal and assigned as observed deaths by age group.

Population estimations

The population for the country in 2020 was estimated using the census population figures of 2011 and the decadal growth rate. We then derived the age group wise population of India based on the current age demographic proportions. We developed the age structure using a uniform distribution of 15 years (<15 years, 15–29 years, 30–44 years, 45–59 years, 60–74 years, ≥75 years).

Crude mortality rate and age-adjusted mortality rate

The crude mortality rate of India and selected states were calculated from the total number of COVID-19 deaths to residents in the specified geographic area divided by the total population for the same geographic area (for a specified time period, usually a calendar year) and multiplied by 100,000. We then calculated the age-adjusted mortality rates by multiplying the crude mortality rate with the standardized mortality rate.

Age standardized mortality rate

We estimated the age-standardized mortality rates of India by calculating the number of COVID-19 deaths for each age group. This was then divided by the age group population that we estimated for per million population. We used the indirect standardization method to calculate the standardized mortality ratio (SMR) by age group for the states. We computed the expected deaths due to COVID-19 for each age group in each state. This was done by applying the estimated ASMR per million population of India (standard population) to the population figures of the state by specific age groups. We then calculated the SMR values for each state with a 95% confidence interval. For estimating the age-standardized mortality rates, we multiplied the crude mortality rate of India with SMR for each state.

The ratio of age standardised mortality

In addition, we attempted to compare the mortality among the age groups within the selected states. We considered the age-standardized mortality of <15 year age group (as this age group was uniformly recorded with the lowest mortality) as the reference. We calculated the ratios of age-standardized mortality for each age group. We performed all the analysis using Microsoft Excel 2018 and Open Epi (an open-source epidemiologic statistics for public health) Version 3.01. We summarised all the estimates in tables and compared them to bring out the state-wise differences in mortality. Ethical consideration The study examined aggregate secondary data from COVID-19 web-based portal on death outcomes and age for selected states in the study period. All statutory permissions were taken from National Centre for Disease Control for the use of the dataset. Names and identifiers were delinked for confidentiality, and only an anonymized dataset was provided to the group on select variables for analysis.

Results

COVID-19 deaths

India had reported a total of 118,883 deaths from March till November 2020. The COVID-19 deaths reported in the selected states by decreasing order were Maharashtra (35978, 30.3%), Delhi (5217, 4.4%), Karnataka (11541, 9.7%), Tamil Nadu (11440, 9.6%), Haryana (1960, 1.6%), West Bengal (5571, 4.7%), and Kerala (1888, 1.6%).

Crude mortality rate and age-adjusted mortality rate

The crude mortality rate of India stands at 88.9 per million population (118,883/1,337,328,910). The crude mortality rate (per million) was observed as highest for Maharashtra (270.4) and lowest in Kerala (53.5). However, the age-adjusted mortality rate (per million) was highest for Delhi (300.5) and lowest for Kerala (35.9) (Table 1 ).
Table 1

Comparison of Crude and Age-Adjusted Mortality Rates for COVID-19, India and its selected States, 2020.

India and its StatesCrude Mortality Rate per millionAge-Adjusted Mortality Rate per million
Maharashtra270.4249.9
Delhi259300.5
Karnataka175.4172.4
Tamil Nadu152.1116.7
Haryana67.873.7
West Bengal57.653.8
Kerala53.535.9
India88.9
Comparison of Crude and Age-Adjusted Mortality Rates for COVID-19, India and its selected States, 2020.

Age standardized mortality rate

The age standardized mortality rate (per million) for India was (<15 years = 1.6, 15–29 years = 6.3, 30–44 years = 35.9, 45–59 years = 198.8, 60–74 years = 571.2, ≥75 years = 931.6) (Table 2 ).
Table 2

Age Standardized Mortality Rates for COVID-19 (per million population) in India and its selected states, 2020.

Age (in years)<1515–2930–4445–5960–74≥75
Maharashtra6.514.598.1522.11640.12818.1
Delhi9.733.9119.3573.61937.33787.9
Karnataka2.410.866.5364.81111.82064.9
Tamil Nadu2.27.045.4231.7773.61385.6
Haryana2.14.531.6146.4489.3837.5
West Bengal1.04.818.1102.3346.1748.4
Kerala0.93.310.958.9242.3490.3
India1.66.335.5198.8571.3931.6
Age Standardized Mortality Rates for COVID-19 (per million population) in India and its selected states, 2020. The age-standardized mortality rates (per million) in the selected states are summarised in Table 2. Across all states, the highest mortality was observed in the age group of ≥75 years; it ranged from 490.3 (Kerala) to 3787.9 (Delhi). We also observed that the mortality rates ranged from 58.9 (Kerala) to 573.6 (Delhi) in 45–59 years. The mortality rates were significantly lower in younger age groups (<29 years) across all states [Table 2.].

The ratio of age standardised mortality

While looking at the ratios for age-standardized mortality, we observed an increasing trend with age across the states. We observed that the COVID-19 mortality among 30–44 years compared to reference differed by a factor ranging between 12 and 28, while among the 45–59 year age group, the factor ranged between 59 and 152, and above 75 year age group the factor ranged between 390 and 860 [Fig. 1 ].
Fig. 1

Ratio of age-standardized mortality due to COVID-19 in India and its selected States, 2020.

Ratio of age-standardized mortality due to COVID-19 in India and its selected States, 2020.

Discussion

Our study examined crude mortality rate, age-adjusted mortality rate, and age-standardized mortalities for COVID-19 in India and seven states. We observed a difference in the crude mortality rate when adjusted for age. Maharashtra, which seemed to have a high crude mortality rate, was replaced by Delhi on adjusting for age, while Kerala remained the lowest in both calculations. Standardization for age identified that the highest mortality rate was among the above 75 year age group; however, it also brought to notice the mortality rate of the 45–59 years age group. This finding was strengthened when comparing the age-standardized mortality within the states. This age group showed an increase in COVID-19 mortality by more than sixty times the reference group. The aggregate confirmed mortality rates tends to conceal the differential impact of the pandemic related to and levels of mortality by age due to demographic composition. Our findings demonstrate the importance of accounting for an age when comparing rates in general and mortality in particular in Indian states. The population age structures are crucial for understanding those at the highest risk of mortality both across and within countries for targeting policies to slow down transmission as well as intergenerational interactions. The overall mortality in India (89.9 deaths per million population) appears to be low compared to the world average; however, this may be attributed to India's age distribution and the data paucity in mortality figures. , We would like to submit that the states with lower age-adjusted mortalities need to ensure the reported mortality figures are complete. The findings of our analysis identified that the COVID-19 mortality risk is higher for the elderly population similar to other countries. , , However; we also observed that the mortality within the age group of 45–59 years which is an active working population group, has been sizeably affected across the states. This evidence is in concurrence with previous reports that suggest a higher caseload exists among the working population when compared to the population share of India. Thus, it is imperative for the government to prioritize this age group in their targeted interventions, implement and ensure adherence to mitigation behaviours, and complete vaccination. We faced limitations in our analysis with regard to the provisional nature of mortality data extracted from the Integrated Disease Surveillance Programme special surveillance portal up to November 16, 2020. We selected six states and one union territory based on the completeness of the information. This could limit the generalizability of results to all the states. However, we also calculated estimates for the national population to understand the overall impact. We also ensured completeness of the available data by cross verifying with the daily COVID-19 bulletins released by the states. Still, some inconsistencies with the final mortality numbers cannot be ruled out due to the lag in COVID-19 death confirmation by the authorities. However, they are unlikely to impact the estimate and standardized mortality rates for comparison between the states and age groups.

Conclusion

We conclude that standardized mortality rate is a useful indicator to identify the vulnerable states and age group in assessing COVID-19 impact. We report that COVID-19 mortality is high among the elderly and the working-age population in the states examined. We recommend further workup and evaluation of age-standardized mortality estimates in all the states and the inclusion of other variables like gender and socio-economic status for standardization while identifying at-risk populations and implementing targeted evidence-based public health actions.

Funding

None.

Statement of authors' contribution

AJ, KKK, TD contributed in study conceptualization, data analysis, data interpretation and manuscript writing and revising; AJ, KA mainly contributed in literature review, data analysis and interpretation; HC, TD, SKJ, SS contributed in data acquisition, interpretation and critical review. All authors read and approved the final version of manuscript.

Declaration of competing interest

There are no conflicts of interest.
  9 in total

1.  Worldwide differences in COVID-19-related mortality.

Authors:  Pedro Curi Hallal
Journal:  Cien Saude Colet       Date:  2020-04-25

2.  Amenable (or avoidable) mortality as an indicator of health system effectiveness.

Authors:  Ruth Lavergne; Kimberly McGrail
Journal:  Healthc Policy       Date:  2014

3.  Estimating COVID-19‒ Related Mortality in India: An Epidemiological Challenge With Insufficient Data.

Authors:  Lauren V Zimmermann; Maxwell Salvatore; Giridhara R Babu; Bhramar Mukherjee
Journal:  Am J Public Health       Date:  2021-07       Impact factor: 9.308

4.  The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper.

Authors:  Stanislaw P Stawicki; Rebecca Jeanmonod; Andrew C Miller; Lorenzo Paladino; David F Gaieski; Anna Q Yaffee; Annelies De Wulf; Joydeep Grover; Thomas J Papadimos; Christina Bloem; Sagar C Galwankar; Vivek Chauhan; Michael S Firstenberg; Salvatore Di Somma; Donald Jeanmonod; Sona M Garg; Veronica Tucci; Harry L Anderson; Lateef Fatimah; Tamara J Worlton; Siddharth P Dubhashi; Krystal S Glaze; Sagar Sinha; Ijeoma Nnodim Opara; Vikas Yellapu; Dhanashree Kelkar; Ayman El-Menyar; Vimal Krishnan; S Venkataramanaiah; Yan Leyfman; Hassan Ali Saoud Al Thani; Prabath Wb Nanayakkara; Sudip Nanda; Eric Cioè-Peña; Indrani Sardesai; Shruti Chandra; Aruna Munasinghe; Vibha Dutta; Silvana Teixeira Dal Ponte; Ricardo Izurieta; Juan A Asensio; Manish Garg
Journal:  J Glob Infect Dis       Date:  2020-05-22

5.  Age-specific and sex-specific adult mortality risk in India in 2014: analysis of 0·27 million nationally surveyed deaths and demographic estimates from 597 districts.

Authors:  Usha Ram; Prabhat Jha; Patrick Gerland; Ryan J Hum; Peter Rodriguez; Wilson Suraweera; Kaushalendra Kumar; Rajesh Kumar; Rajesh Dikshit; Denis Xavier; Rajeev Gupta; Prakash C Gupta; Faujdar Ram
Journal:  Lancet Glob Health       Date:  2015-12       Impact factor: 26.763

6.  Projections of global mortality and burden of disease from 2002 to 2030.

Authors:  Colin D Mathers; Dejan Loncar
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

7.  Demographic science aids in understanding the spread and fatality rates of COVID-19.

Authors:  Jennifer Beam Dowd; Liliana Andriano; David M Brazel; Valentina Rotondi; Per Block; Xuejie Ding; Yan Liu; Melinda C Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-16       Impact factor: 11.205

8.  Demographic perspectives on the mortality of COVID-19 and other epidemics.

Authors:  Joshua R Goldstein; Ronald D Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-20       Impact factor: 11.205

9.  Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England.

Authors:  Mark Joy; Fd Richard Hobbs; Jamie Lopez Bernal; Julian Sherlock; Gayatri Amirthalingam; Dylan McGagh; Oluwafunmi Akinyemi; Rachel Byford; Gavin Dabrera; Jienchi Dorward; Joanna Ellis; Filipa Ferreira; Nicholas Jones; Jason Oke; Cecilia Okusi; Brian D Nicholson; Mary Ramsay; James P Sheppard; Mary Sinnathamby; Maria Zambon; Gary Howsam; John Williams; Simon de Lusignan
Journal:  Br J Gen Pract       Date:  2020-11-26       Impact factor: 5.386

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.